Cargando…
OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics
B cells are pathogenic in various disease processes and therefore represent an interesting target for the development of novel immunosuppressants. In the search for new therapeutic molecules, we utilized an in vitro B cell activation assay with ODN2006-stimulated Namalwa cells to screen a chemical l...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157143/ https://www.ncbi.nlm.nih.gov/pubmed/30276218 http://dx.doi.org/10.1155/2018/2505818 |